The bill, H.B. No. 125, proposes amendments to the Texas Controlled Substances Act by designating certain substances as Schedule IV controlled substances. Specifically, the bill adds carisoprodol, mifepristone, and misoprostol to the list of Schedule IV substances, while removing the previous designation of carisoprodol as a standalone entry. This change aims to regulate these substances more effectively under Texas law.

The bill stipulates that the changes will only apply to offenses committed on or after its effective date of January 1, 2026. Any offenses that occurred prior to this date will be governed by the law in effect at that time, ensuring that individuals are not retroactively penalized under the new regulations.

Statutes affected:
Introduced: Health and Safety Code 481.037 (Health and Safety Code 481)